1. Wenande E, Garvey L. Immediate-type hypersensitivity to polyethylene glycols: a review. Clin Exp Allergy. 2016;46(7):907-22.
2. Bruusgaard-Mouritsen M, Johansen J, Garvey L. Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients. Clin Exp Allergy. 2021;51(3):463-70.
3. Sellaturay P, Nasser S, Ewan P. Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis). J Allergy Clin Immunol Pract. 2021;9(2):670-5.
4. Zhou Z, Stone C, Jakubovic B, Phillips E, Sussman G, Park J et al. Anti-PEG IgE in anaphylaxis associated with polyethylene glycol. J Allergy Clin Immunol Pract. 2021;9(4):1731-3.e3.
5. Mohamed M, Abu Lila A, Shimizu T, Alaaeldin E, Hussein A, Sarhan H et al. PEGylated liposomes: immunological responses. Sci Technol Adv Mater. 2019;20(1):710-724.
6. Jover Cerdá V, Rodríguez Pacheco R, Doménech Witek J, Marco de la Calle F, de la Sen Fernández M. Immediate hypersensitivity to polyethylene glycols in unrelated products: when standardization in the nomenclature of the components of drugs, cosmetics, and food becomes necessary. Allergy Asthma Clin Immunol. 2019;15(1).
7. Sellaturay P, Nasser S, Islam S, Gurugama P, Ewan P. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine. Clin Exp Allergy. 2021;51(6):861-3.
8. Freire Haddad H, Burke J, Scott E, Ameer G. Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly (Ethylene Glycol) Antibodies. Regen Eng Transl Med. 2021;1-11.
9. Liu Y, Smith C, Payton M, Jenkins D, Janke L, Relling M. An injectable excipient prevents anti-polyethylene glycol antibody-mediated hypersensitivity. Allergy. 2021;76(9):2902-4.
10. Ieven T, Van Weyenbergh T, Vandebotermet M, Devolder D, Breynaert C, Schrijvers R. Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients. J Allergy Clin Immunol Pract. 2021;9(12):4470-2.e1.